Studies on the genotoxic and mutagenic potentials of mefloquine
Trop. j. pharm. res. (Online)
; 1(2): 91-98, 2003.
Article
in English
| AIM
| ID: biblio-1273047
Responsible library:
CG1.1
ABSTRACT
PURPOSE:
The detection of mefloquine mutagenicity has not been achieved by the use of Salmonella typhimurium his TA1535; TA1537 as tester strains. With the introduction of improved and more sensitive strains; it is of interest to evaluate the current mutagenic and genotoxic status of the drug. This study presents data on the in-vitro mutagenic and genotoxic potentials of mefloquine hydrochloride clinically used as an antimalarial agent.METHOD:
The mutagenicity potentials was investigated in the Escherichia coli WP[2] trp and WP[2] uvrA trp tester strains containing the plasmids; pEB017 and pKM101; and the Salmonella typhimurium TA97 containing pKM101. The genotoxicity potential was determined using the microscreen phage-induction assay.RESULTS:
The presence of plasmids pEBO17 and pKM101 enhanced the detection of mutagenicity of mefloquine. Microsomal-activated mefloquine unequivocally elicited base-pair substitution mutagenicity. The genotoxicity test indicated that mefloquine was generally not genotoxic but was of the same potential mutagenicity as chloroquine phosphate.CONCLUSION:
Melfloquine hydrochloride exhibits base pair substitution mutagenesis; but not potentially genotoxic; even though it showed concentration dependent cytotoxicity. Its use as a last line antimalarial agent should still be encouraged
Search on Google
Index:
AIM (Africa)
Main subject:
Salmonella typhimurium
/
Mefloquine
/
Mutagenicity Tests
/
Antimalarials
Language:
English
Journal:
Trop. j. pharm. res. (Online)
Year:
2003
Type:
Article
Similar
MEDLINE
...
LILACS
LIS